id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0597-0063,FDA,FDA-2011-D-0597,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2019-09-12T04:00:00Z,2019,9,2019-09-12T04:00:00Z,,2022-11-22T18:59:39Z,2019-19779,0,0,0900006483f49943
FDA-2011-D-0597-0062,FDA,FDA-2011-D-0597,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Oversight of
Clinical Investigations: A Risk-Based Approach to Monitoring",Notice,30 Day Proposed Information Collection,2019-04-16T04:00:00Z,2019,4,2019-04-16T04:00:00Z,2019-05-17T03:59:59Z,2019-04-16T14:12:14Z,2019-07523,0,0,0900006483bac96d
FDA-2011-D-0597-0060,FDA,FDA-2011-D-0597,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Oversight of Clinical Investigations: A Risk-Based
Approach to Monitoring",Notice,60 Day Proposed Information Collection,2018-11-30T05:00:00Z,2018,11,2018-11-30T05:00:00Z,2019-01-30T04:59:59Z,2022-11-22T18:59:11Z,2018-26032,0,0,0900006483915d45
FDA-2011-D-0597-0059,FDA,FDA-2011-D-0597,"Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approvals",Notice,Notice of Approval,2016-07-11T04:00:00Z,2016,7,2016-07-11T04:00:00Z,,2016-07-11T13:40:56Z,2016-16349,0,0,090000648209c0b5
FDA-2011-D-0597-0058,FDA,FDA-2011-D-0597,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Guidance for Industry on Oversight of
Clinical Investigations: A Risk-Based Approach to Monitoring",Notice,30 Day Proposed Information Collection,2015-12-17T05:00:00Z,2015,12,2015-12-17T05:00:00Z,2016-01-20T04:59:59Z,2015-12-17T14:54:03Z,2015-31695,0,0,0900006481db6a1d
FDA-2011-D-0597-0055,FDA,FDA-2011-D-0597,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Guidance for Industry on Oversight of Clinical
Investigations: A Risk-Based Approach To Monitoring",Notice,60 Day Proposed Information Collection,2015-07-14T04:00:00Z,2015,7,2015-07-14T04:00:00Z,2015-09-15T03:59:59Z,2015-09-12T01:30:55Z,2015-17318,0,0,0900006481b82f1c
FDA-2011-D-0597-0053,FDA,FDA-2011-D-0597,Guidance for Industry on Oversight of Clinical Investigations--A Risk-Based Approach to Monitoring,Other,Guidance,2013-08-07T04:00:00Z,2013,8,2013-08-07T04:00:00Z,,2024-11-07T22:58:12Z,,1,0,0900006481395793
FDA-2011-D-0597-0052,FDA,FDA-2011-D-0597,Guidance for Industry on Oversight of Clinical Investigations--A Risk-Based Approach to Monitoring; Availability,Notice,Notice of Availability,2013-08-07T04:00:00Z,2013,8,2013-08-07T04:00:00Z,,2015-07-07T16:52:03Z,2013-19004,0,0,0900006481394d5e
FDA-2011-D-0597-0050,FDA,FDA-2011-D-0597,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Draft Guidance for Industry; Oversight of Clinical Investigations; A Risk-Based Approach to Monitoring",Notice,30 Day Proposed Information Collection,2012-09-25T04:00:00Z,2012,9,2012-09-25T04:00:00Z,2012-10-26T03:59:59Z,2015-07-07T16:54:15Z,2012-23545,0,0,090000648112654c
FDA-2011-D-0597-0001,FDA,FDA-2011-D-0597,Draft Guidance for Industry; Availability: Oversight of Clinical Investigations; A Risk-Based Approach to Monitoring,Notice,Notice of Availability,2011-08-29T04:00:00Z,2011,8,2011-08-29T04:00:00Z,2011-11-29T04:59:59Z,2011-08-29T14:24:36Z,2011-21972,0,0,0900006480f07901
FDA-2011-D-0597-0002,FDA,FDA-2011-D-0597,Draft Guidance for Industry; Oversight of Clinical Investigations; A Risk-Based Approach to Monitoring,Other,Guidance,2011-08-29T04:00:00Z,2011,8,2011-08-29T04:00:00Z,,2019-10-21T13:49:09Z,,0,0,0900006480f07410